Do you want to read an article? Please log in or register.
Advanced Gastric Cancer: Current Treatment Landscape and a Future Outlook for Sequential and Personalized Guide: Swiss Expert Statement Article
Gastrointestinal Cancer
Related content
Breast Cancer
Recent Developments in Metastatic Breast Cancer
healthbook TIMES Oncology Hematology
Genitourinary Cancer
The Evolving Systemic Treatment Landscape for Patients with Advanced Prostate Cancer
Drugs.
Pagliuca M, Buonerba C, Fizazi K, Di Lorenzo G
doi: 10.1007/s40265-019-1060-5.
Breast Cancer
Breast Cancer Treatment in the Era of Precision Medicine
1Breast Cancer Center, University Hospital Basel, Spitalstrasse 21, 4031 Basel, Switzerland
Further Publications
Precision Oncology for Hepato-Pancreato-Biliary (HPB) Cancers: State of the Art and Future Directions
★ 3
Recommended and commented by
Alexander Meisel, Faculty Member
1Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland
*equal contribution
Gastrointestinal Cancer
Lenvatinib plus pembrolizumab in patients with advanced gastric cancer in the first-line or second-line setting (EPOC1706): an open-label, single-arm, phase 2 trial
Lancet Oncol.
Kawazoe A, Fukuoka S, Nakamura Y, Kuboki Y, Wakabayashi M, Nomura S, Mikamoto Y, Shima H, Fujishiro N, Higuchi T, Sato A, Kuwata T, Shitara K
doi: 10.1016/S1470-2045(20)30271-0.
Gastrointestinal Cancer
Treatment landscape of metastatic pancreatic cancer
Cancer Treat Rev
De Dosso S, Siebenhüner AR, Winder T, Meisel A, Fritsch R, Astaras C, Szturz P, Borner M
doi: 10.1016/j.ctrv.2021.102180
Gastrointestinal CancerFurther Publications
Targeting the Tumor in Colorectal Cancer – Where do we Stand with Precision Medicine in 2020
★ 3
Recommended and commented by
Alexander Meisel, Faculty Member
healthbook TIMES Oncology Hematology
Corresponding author:
Dr Alexander Siebenhüner
Senior Consultant in Medical Oncology
Cantonal Hospital Schaffhausen
Schaffhausen, Switzerland
Radio-Oncology
Immunotherapy in head and neck cancer - scientific rationale, current treatment options and future directions
Swiss Med Wkly.
Rothschild U, Muller L, Lechner A, Schlösser HA, Beutner D, Läubli H, Zippelius A, Rothschild SI
doi: 10.4414/smw.2018.14625.
Lung Cancer
Molecular Diagnostic and Precision Medicine in Non-Small Cell Lung Cancer. An Update on the Treatment of the Most Important Actionable Oncogenic Driver Alterations.
1Department of Medical Oncology, University Hospital Basel, Basel, Switzerland.